Physician profile
Saba Aftab
NPI 1760674287
$6,187.19
in general payments reported to CMS, 2019-2025
37 companies · $1,602 in 2025
The $1,602 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $328 · 2021: $1,171 · 2022: $661 · 2023: $873 · 2024: $911 · 2025: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,331 · Education: $54.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,330.55 |
| Education | $54.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,227.61 | 2021-2025 | Inspire |
| Genzyme Corporation | $878.67 | 2019-2025 | |
| Glaxosmithkline, LLC. | $470.71 | 2021-2025 | Nucala |
| Optinose US, INC. | $444.61 | 2019-2025 | |
| Alk-Abello, INC | $364.84 | 2019-2023 | Odactra, Ragwitek, Grastek |
| Regeneron Healthcare Solutions, INC. | $278.31 | 2019-2024 | Dupixent |
| Abbott Laboratories | $252.52 | 2022-2024 | Freestyle Libre 3 |
| Kaleo, INC. | $189.00 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $176.64 | 2021-2024 | |
| Hologic Sales and Service, LLC | $171.02 | 2024-2025 | Coolseal Generator |
| Medtronic, INC. | $164.03 | 2025 | Pteye Parathyroid Detection System, Propel |
| Intersect Ent, INC. | $154.31 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $146.44 | 2019-2021 | |
| Cochlear Americas | $123.18 | 2019-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Ascendis Pharma Endocrinology INC | $120.29 | 2025 | Yorvipath |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $118.01 | 2022 | |
| Stryker Corporation | $109.69 | 2019-2025 | Audion Et Dilation System, Nasopore |
| Aerin Medical INC. | $97.48 | 2020-2025 | |
| Abbvie INC. | $91.32 | 2019 | |
| Insulet Corporation | $76.78 | 2021 | |
| Smith+Nephew, INC. | $67.41 | 2021-2025 | Tula |
| Acclarent, INC | $65.59 | 2019-2023 | Acclarent Aera, Relieva Spinplus |
| Dexcom, INC. | $52.87 | 2021 | |
| Arbor Pharmaceuticals, INC. | $39.78 | 2019 | |
| Lilly USA, LLC | $35.02 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $33.98 | 2024 | Lumryz |
| Phadia US INC. | $32.01 | 2021-2025 | Immunocap |
| Quidel Corporation | $31.76 | 2019 | |
| Greer Laboratories, INC. | $29.67 | 2019 | |
| Merck Sharp & Dohme LLC | $29.22 | 2021-2023 | |
| Karl Storz Endoscopy-America | $21.50 | 2020 | |
| Fujifilm New Development USA, INC. | $20.65 | 2019 | |
| Resmed Corp | $18.05 | 2019 | |
| Olympus America INC. | $16.28 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.21 | 2025 | Xhance |
| Novartis Pharmaceuticals Corporation | $11.73 | 2019 | |
| Glenmark Therapeutics INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saba Aftab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.